TY - JOUR
T1 - Contrasting clinical and statistical significance within the research setting
AU - Lindgren, Bruce R
AU - Wielinski, Catherine L.
AU - Finkelstein, Stanley M
AU - Warwick, Warren J.
PY - 1993/12
Y1 - 1993/12
N2 - When designing a clinical trial or study, the value of the following interrelated parameters should be determined prior to collecting data: clinical significance, statistical significance, power, and sample size. Too often, clinical importance and the other design issues are ignored and only statistical significance dictates the conclusions of the study. In order to evaluate the frequency that each of these design parameters is addressed in the published literature, the topic of pulmonary function tests (specifically forced vital capacity) was chosen, and all relevant articles for one year (1990) were identified using Minnesota MEDLINE. A total of 121 articles met the selection criteria and were reviewed. Of all the articles, 13.2% discussed clinical significance, 21.5% discussed sample size, and only 5.0% addressed statistical power. As expected, the majority of the articles (92.6%) discussed statistical significance (P values). None of the articles mentioned all four factors. When choosing the level of clinical significance several methods may be used. Such might be well established in certain clinical areas or available from previous publications and references or they may be attainable from pilot study data and, in the absence of any prior information, a clinician may use personal experience. To minimize subjectivity, the clinical effect‐size can be based on the population distribution of the measurement of interest. Pediatr Pulmonol. 1993; 16:336–340. © 1993 Wiley‐Liss, Inc.
AB - When designing a clinical trial or study, the value of the following interrelated parameters should be determined prior to collecting data: clinical significance, statistical significance, power, and sample size. Too often, clinical importance and the other design issues are ignored and only statistical significance dictates the conclusions of the study. In order to evaluate the frequency that each of these design parameters is addressed in the published literature, the topic of pulmonary function tests (specifically forced vital capacity) was chosen, and all relevant articles for one year (1990) were identified using Minnesota MEDLINE. A total of 121 articles met the selection criteria and were reviewed. Of all the articles, 13.2% discussed clinical significance, 21.5% discussed sample size, and only 5.0% addressed statistical power. As expected, the majority of the articles (92.6%) discussed statistical significance (P values). None of the articles mentioned all four factors. When choosing the level of clinical significance several methods may be used. Such might be well established in certain clinical areas or available from previous publications and references or they may be attainable from pilot study data and, in the absence of any prior information, a clinician may use personal experience. To minimize subjectivity, the clinical effect‐size can be based on the population distribution of the measurement of interest. Pediatr Pulmonol. 1993; 16:336–340. © 1993 Wiley‐Liss, Inc.
KW - Power
KW - forced vital capacity
KW - pulmonary function tests
KW - sample size
UR - http://www.scopus.com/inward/record.url?scp=0027712488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027712488&partnerID=8YFLogxK
U2 - 10.1002/ppul.1950160603
DO - 10.1002/ppul.1950160603
M3 - Article
C2 - 8134154
AN - SCOPUS:0027712488
SN - 8755-6863
VL - 16
SP - 336
EP - 340
JO - Pediatric pulmonology
JF - Pediatric pulmonology
IS - 6
ER -